100s of titles, one news app for just $10 a month.
Dive Deeper:
Abbott says two months for baby formula to hit shelves amid US shortage
US manufacturer forced to close Michigan plant after reports of illness and death that prompted federal investigation
House Oversight Committee launches probe into baby formula manufacturers amid nationwide shortage
‘The national formula shortage poses a threat to the health and economic security of infants and families in communities across…
Company says it could restart production of baby formula within weeks amid severe shortage
Joe Biden set to discuss the issue and ways to address the shortage with manufacturers
Infant formula shortage suddenly Topic A in Washington
The problem has been brewing for months, but politicians in both parties have recently seized on the issue, as the…
One subscription that gives you access to news from hundreds of sites
Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales
CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the…
US parents swap and sell baby formula amidst country-wide shortage
A US-wide baby formula shortage forces frenzied parents into online groups to swap and sell to each other to keep…
Get all your news in one place
Latest Business news:
Age of Scarcity Begins With $1.6 Trillion Hit to World Economy
New fault-lines are likely to outlast war and plague — leaving the global economy smaller and prices higher.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Sydney-based startup Space Machines Company partners with SpaceX
Sydney-based in-space logistics startup Space Machines Company has partnered with Elon Musk’s SpaceX to launch its spacecraft next year. Space…
How a Trash-Talking Crypto Bro Caused a $40 Billion Crash
Do Kwon, a trash-talking entrepreneur from South Korea, called the cryptocurrency he created in 2018 “my greatest invention.” In countless…
Google’s Russian business plans to file for bankruptcy
Google says its Russian subsidiary is planning to file for bankruptcy because it can't pay staff and suppliers. Russian state…
SA moves to scrap tax on electric vehicles
South Australia's new Labor government has delivered on one of its election promises and moved to scrap plans for a…
From analysis to good news, read the world’s best news in one place
Crypto billionaire Sam Bankman-Fried: ‘I got involved with no clue what a blockchain was’
The FTX founder on hype, the problem with bitcoin and how crypto can build a fairer financial system
Wall Street stocks tumble following weak results from retailers
New York (AFP) - Wall Street stocks suffered one of their worst batterings since 2020 on Wednesday, as downcast earnings…

After baby formula recall, Abbott says it can restart production at Michigan site within 2 weeks of FDA approval

By Lisa Schencker

Abbott Laboratories said it could have some of its recalled infant formulas back on store shelves within eight to 10 weeks after the U.S. Food and Drug Administration gives its approval, though it’s unclear when that approval may come.

For months, parents and babies have endured a nationwide shortage of infant formulas, partly linked to Abbott’s February recall of Similac, Similac Alimentum and EleCare powder formulas made at a Sturgis, Michigan, facility as the FDA investigated complaints of Cronobacter sakazakii infections among four babies who reportedly consumed formula made there. All four babies were hospitalized, and Cronobacter may have contributed to two babies’ death, according to the FDA.

North suburban-based Abbott said in a statement Wednesday that it has taken action to address issues in its Sturgis plant, and it could restart production there within two weeks of getting approval from the FDA. Once it has that approval, it would first produce EleCare, Similac Alimentum and metabolic formulas, which are formulas for babies with special nutritional needs. It would then resume production of Similac and other formulas, according to the statement. Once production is restarted, it would take six to eight weeks before the products would return to stores.

“We understand the situation is urgent — getting Sturgis up and running will help alleviate this shortage,” Abbott said in the statement.

It’s not clear, however, exactly when the FDA will give Abbott a green light to restart production at the facility.

The FDA said in a statement Thursday that it recognizes consumers are frustrated that they can’t find many types of formula, and the FDA is “doing everything in its power to ensure there is adequate product available where and when they need it.”

“At the same time, it is important that the FDA continue its work to ensure that Abbott can undertake safe resumption of production of infant formula at Abbott Nutrition’s Sturgis, Michigan facility, to further alleviate these supply challenges, which remains an important focus,” the FDA statement said. “The plant remains closed as the company works to correct findings related to the processes, procedures, and conditions that the FDA observed during its inspection of the facility from January 31 – March 18, 2022.”

During that inspection, the FDA found five environmental subsamples collected from the Sturgis facility to be positive for Cronobacter sakazakii, though product samples collected by the FDA at the facility were negative for Cronobacter.

Abbott said the Cronobacter that was found in environmental testing during the investigation was in “non-product contact areas of the facility and has not been linked to any known infant illness.”

Abbott said it has reviewed and updated its education, training and safety procedures for employees and visitors; updated its protocols related to water and cleaning and maintenance procedures; and has been upgrading the plant, including by installing nonporous, “easily cleanable and sanitary floors.”

Abbott is facing a number of lawsuits filed by parents over the recalled formulas.

Parents in Illinois and across the country are eager to see an end to the formula shortage, which has been partly caused by supply chain issues. Formulas made by Abbott are not the only ones in short supply.

Many grocery stores and retail pharmacy chains, including Jewel-Osco, Walgreens and CVS Health, are limiting how much formula people can buy at once.

In the Chicago area, about 34% of formulas were out of stock at local stores the first week of May, up from 28% at the beginning of March, according to Datasembly, a company that scrapes data from retailers’ publicly available websites and apps to gauge product availability. During the first half of 2021, only about 2% to 8% of formulas were out of stock nationwide.

The FDA said in a news release earlier this week that it’s been meeting with major infant formula manufacturers to understand their capacity to increase production, and several companies are already working to ramp up production. It also said that even before the Abbott recall it was “working to address supply chain issues associated with the pandemic including those impacting the infant formula industry.”

The FDA has said parents should never dilute formula, use homemade formula or buy imported formula online, as it could be counterfeit. If a baby or child’s regular formula isn’t available, the FDA advises parents to talk with their pediatricians for recommendations.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Abbott says two months for baby formula to hit shelves amid US shortage
US manufacturer forced to close Michigan plant after reports of illness and death that prompted federal investigation
House Oversight Committee launches probe into baby formula manufacturers amid nationwide shortage
‘The national formula shortage poses a threat to the health and economic security of infants and families in communities across…
Company says it could restart production of baby formula within weeks amid severe shortage
Joe Biden set to discuss the issue and ways to address the shortage with manufacturers
Infant formula shortage suddenly Topic A in Washington
The problem has been brewing for months, but politicians in both parties have recently seized on the issue, as the…
One subscription that gives you access to news from hundreds of sites
Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales
CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the…
US parents swap and sell baby formula amidst country-wide shortage
A US-wide baby formula shortage forces frenzied parents into online groups to swap and sell to each other to keep…
Get all your news in one place